Evidence map›Paper›PMID 41028270›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Deciphering the Tumor Microenvironment Composition Using Bulk Transcriptomics: A Guide to Recent Advances and Open Challenges.

Sotiris Ouzounis, Donya Zojaji, Sandra García-Mulero, Marco Barreca, Paolo Gandellini, Theodora Katsila, Rebeca Sanz-Pamplona, Maurizio Callari

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sotiris OuzounisInstitute of Chemical Biology, National Hellenic Research Foundation, Athens, Greece.
Donya ZojajiFondazione Michelangelo, Milan, Italy.
Sandra García-MuleroDepartment of Pathology and Experimental Therapy, ONCOBELL Program, Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, Spain.
Marco BarrecaFondazione Michelangelo, Milan, Italy.
Paolo GandelliniDepartment of Biosciences, University of Milan, Milan, Italy.
Theodora KatsilaInstitute of Chemical Biology, National Hellenic Research Foundation, Athens, Greece.
Rebeca Sanz-PamplonaCancer Heterogeneity and Immunomics (CHI) Group, University Hospital Lozano Blesa, Aragon Health Research Institute (IISA), Zaragoza, Spain.
Maurizio CallariFondazione Michelangelo, Milan, Italy. maurizio.callari@fondazionemichelangelo.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumors are complex ecosystems comprising diverse cell types actively participating to carcinogenesis, tumor progression, and treatment response. Understanding the tumor microenvironment (TME) dynamics has become of primary importance, especially with the increasing clinical implementation of immunotherapy. Low and high-throughput single cell and spatial technologies are providing high-resolution strategies for the study of the tumor ecosystem. However, their cost and complexity limit widespread use. Bulk transcriptomics has become a widely used strategy to obtain the expression profile of large cohorts of tumors or preclinical models. Several methods implementing a deconvolution analysis have been developed to estimate from bulk transcriptomics the prevalence of multiple cell types to reconstruct the tumor ecosystem composition.In this chapter, we introduce deconvolution analysis, the main steps, the recent advancements, and open challenges. Our emphasis lies on robust benchmarking methodologies, highlighting the importance of clear parameter definition and appropriate metric selection for reliable results across different software tools.Using CIBERSORTx and BayesPrism, we conduct a practical analysis on triple-negative breast cancer (TNBC) datasets from The Cancer Genome Atlas (TCGA) dataset. We illustrate the impact of various factors such as preprocessing methods, reference datasets, and software choice on deconvolution outcomes.Integrating insights from benchmarking analyses and real-world applications, we provide guidance to optimize and control for the quality of deconvolution analysis, weighting both its potential and limitations. Deconvolution analysis can contribute to unravelling the complexities of the tumor microenvironment, but further research is needed to enhance accuracy and reproducibility.

Indexed as

Computational BiologyGene Expression ProfilingTranscriptomeTriple Negative Breast NeoplasmsTumor MicroenvironmentFemaleGene Expression Regulation, NeoplasticHumansSingle-Cell AnalysisSoftwareBulkCancerCell typeChallengesDeconvolutionImmuneMicroenvironmentTMETranscriptomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.